Adverum Biotech

9 followers


Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more

Industries

Employees

51-200

Links


Org chart

Laurent Fischer
President & CEO
Collapse
Star Seyedkazemi
Chief Development Officer
R. Andrew Ramelmeier
Chief Technology Officer
Romuald Corbau
Chief Scientific Officer
Jason L. Mitchell
Chief Commercial Officer
John Rakow
Senior Legal Advisor
Dena House
SVP, Human Resources, Organizational Development & Learning
Heikki Jouttijärvi
SVP & Head, Technical Operations
Bill Tan
SVP & Head, Global Clinical Operations
Adam Turpcu
Svp, Clinical Development
Aneta Ferguson
Svp, General Counsel
Andy Ramelmeier
Chief Technology Officer
Peter Soparkar
Chief Operating Officer
Kathryn Ask
Senior Executive Assistant - C-suite & Board Of Directors

Board & advisors